This is a preview of subscription content, access via your institution
Access options
References
Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242–1250.
Marino IR, Panarello G, Singh N . Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients. Transpl Infect Dis 2002; 4: 226–227; author reply.
Maertens J, Deeren D, Dierickx D, Theunissen K . Preemptive antifungal therapy: still a way to go. Curr Opin Infect Dis 2006; 19: 551–556.
Rapid test for Aspergillus infection. FDA Consum 2003; 37: 7.
Sinko J, Csomor J, Nikolova R, Lueff S, Krivan G, Remenyi P et al. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey. Transpl Infect Dis 2008; 10: 106–109.
Steinbach WJ, Addison RM, McLaughlin L, Gerrald Q, Martin PL, Driscoll T et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007; 26: 558–564.
Rooney S, Sekiguchi J, Zhu C, Cheng HL, Manis J, Whitlow S et al. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell 2002; 10: 1379–1390.
Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45: 1161–1170.
Post MJ, Lass-Floerl C, Gastl G, Nachbaur D . Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients. Transpl Infect Dis 2007; 9: 189–195.
Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of interest
The authors do not have a commercial or other association that might pose a conflict of interest (for example, pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents or research funding). Financial support was provided by the MSKCC Department of Medicine.
Rights and permissions
About this article
Cite this article
Jathavedam, A., Duré, D., Taur, Y. et al. Limited utility of serum galactomannan assay after auto-SCT. Bone Marrow Transplant 44, 59–61 (2009). https://doi.org/10.1038/bmt.2008.425
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.425